Abstract
The effects of cyclic nucleotide phosphodiesterase (PDE) inhibitors on cell proliferation of SK-N-MC human neuroepithelioma cell line was studied. Clonal density experiments in the presence of 100 μM rolipram and zaprinast showed respectively 27% and 91% inhibition. The effects of PDE inhibitors were then investigated on crude cell extracts; the calculated IC50 were 32 μM for zaprinast and 16 nM for DC-TA-46; the latter inhibitor was used instead of rolipram for itshigher efficacy. Dose-response experiments in clonal density conditions showed IC50 of 5 μM and 1.8 μM in the presence respectively of zaprinast and rolipram. These data show that both inhibitors are effective in reducing cell growth, although the response was quantitatively different.
Similar content being viewed by others
References
Friedman DL: Role of cyclic nucleotides in cell growth and differentiation. Physiological Rev 56(4): 652–708, 1976
Cook SJ, McCornick F: Inhibition by cAMP of Ras-dependent activation of Raf. Science 262: 1069–1072, 1993
Furmanski P, Silverman DJ, Lubin M: Expression of differentiated functions in mouse neuroblastoma mediated by dibutyryl-cyclic adenosine monophosphate. Nature 233: 413–415, 1971
Marangos PJ, Goodwin FK, Parma A, Lauter C, Trams E: Neuron specific protein (NSP) in neuroblastoma cells: relation to differentiation. Brain Res 145: 49–58, 1978
Richelson E: Stimulation of Tyrosine Hydroxylase activity in an adrenergic clone of mouse neuroblastoma by dibutyryl cyclic AMP. Nat New Biol 242: 175–177, 1973
Prasad KN, Hsie W: Morphologic differentiation of mouse neuroblastoma cells induced in vitro by dibutyryl adenosine 3′,5′-cyclic monophosphate. Nat New Biol 233: 141–142, 1971
Bentley JK, Beavo JA: Regulation and function of cyclic nucleotides. Curr Opin Cell Biol 4: 233–240, 1992
Conti M, Nemoz G, Sette C, Vicini E: Recent progress in understanding the hormonal regulation of phosphodiesterase. Endocrine Rev 16: 370–389, 1995
Beavo JA, Reifsnyder DH: Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Physiol Sci 11: 150–155 1990
Beavo JA: Multiple isoenzymes of cyclic nucleotide phosphodiesterase. Adv Second Messengers Phosphoprotein Res 22: 1–38, 1988
Thiele CJ, McKeon C, Triche TJ, Ross RA, Reynolds P, Israel MA: Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J Clin Invest 80: 804–811, 1987
Thompson WJ, Appleman MM: Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 10: 311–316, 1971
Campagnolo L, Giorgi M, Augusti-Tocco G: Caratterizzazione della attività fosfodiesterasica per i nucleotidi ciclici nel neuroblastoma umano SK-N-MC. Abstract, VI Congresso Società Italiana di Neuroscienze, Milano, 1995
Drees M, Zimmermann R, Eisenbrand G: 3′,5′-cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition. Cancer Res 53: 3058–3061, 1993
Denis-Donini S, Augusti-Tocco G: Molecular and lectin probe analysis of neuronal differentiation. Curr Topics Devel Biol 16: 323–348, 1980
Tisdale MJ, Phillis BJ: Inhibition of cyclic 3′,5′-nucleotide phosphodiesterase a possible mechanism of action of bifunctional alkylating agents. Biochem Pharmacol 24: 211–217, 1975
Nitschke R, Cangir A, Crist W, Berry DH: Intensive chemotherapy for metastatic neuroblastoma: a southwest oncology group study. Med Pediatr Oncol 8: 281–288, 1980
Janik P, Assaf A, Bertram JS: Inhibition of growth of primary and metastatic Lewis lung carcinoma cells by phosphodiesterase inhibitor isobutylmethylxanthine. Cancer Res 40: 1950–1954, 1980
Lichtner RB, Goka TJ, Butcher RW, Nicolson GL: Direct effects of the pyrimido-pyrimidine derivate RA233 (Raptenon) on rat 13762NF mammary tumor cell clones. Cancer Res 47: 1870–1877, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Campagnolo, L., Giorgi, M. & Augusti-Tocco, G. Phosphodiesterase specific inhibitors control cell growth of a human neuroepithelioma cell line. J Neurooncol 31, 123–127 (1997). https://doi.org/10.1023/A:1005758103118
Issue Date:
DOI: https://doi.org/10.1023/A:1005758103118